Annual CFO
-$74.76 M
-$58.33 M-355.11%
31 December 2023
Summary:
Apogee Therapeutics annual cash flow from operations is currently -$74.76 million, with the most recent change of -$58.33 million (-355.11%) on 31 December 2023. APGE annual CFO is now -355.11% below its all-time high of -$16.43 million, reached on 31 December 2022.APGE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$42.52 M
-$13.22 M-45.13%
30 September 2024
Summary:
Apogee Therapeutics quarterly cash flow from operations is currently -$42.52 million, with the most recent change of -$13.22 million (-45.13%) on 30 September 2024. Over the past year, it has dropped by -$22.64 million (-113.90%). APGE quarterly CFO is now -302.80% below its all-time high of -$10.56 million, reached on 31 March 2023.APGE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$133.21 M
-$22.64 M-20.48%
30 September 2024
Summary:
Apogee Therapeutics TTM cash flow from operations is currently -$133.21 million, with the most recent change of -$22.64 million (-20.48%) on 30 September 2024. Over the past year, it has dropped by -$88.21 million (-195.99%). APGE TTM CFO is now -1161.85% below its all-time high of -$10.56 million, reached on 31 March 2023.APGE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APGE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -355.1% | -113.9% | -196.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APGE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -355.1% | at low | -302.8% | at low | -1161.8% | at low |
| 5 y | 5 years | -355.1% | at low | -302.8% | at low | -1161.8% | at low |
| alltime | all time | -355.1% | at low | -302.8% | at low | -1161.8% | at low |
Apogee Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$42.52 M(+45.1%) | -$133.21 M(+20.5%) |
| June 2024 | - | -$29.30 M(-7.4%) | -$110.57 M(+15.4%) |
| Mar 2024 | - | -$31.64 M(+6.3%) | -$95.84 M(+28.2%) |
| Dec 2023 | -$74.76 M | -$29.75 M(+49.7%) | -$74.76 M(+66.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$19.88 M(+36.4%) | -$45.01 M(+79.1%) |
| June 2023 | - | -$14.57 M(+38.0%) | -$25.13 M(+138.0%) |
| Mar 2023 | - | -$10.56 M | -$10.56 M |
| Dec 2022 | -$16.43 M | - | - |
FAQ
- What is Apogee Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Apogee Therapeutics?
- What is Apogee Therapeutics annual CFO year-on-year change?
- What is Apogee Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly CFO year-on-year change?
- What is Apogee Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Apogee Therapeutics?
- What is Apogee Therapeutics TTM CFO year-on-year change?
What is Apogee Therapeutics annual cash flow from operations?
The current annual CFO of APGE is -$74.76 M
What is the all time high annual CFO for Apogee Therapeutics?
Apogee Therapeutics all-time high annual cash flow from operations is -$16.43 M
What is Apogee Therapeutics annual CFO year-on-year change?
Over the past year, APGE annual cash flow from operations has changed by -$58.33 M (-355.11%)
What is Apogee Therapeutics quarterly cash flow from operations?
The current quarterly CFO of APGE is -$42.52 M
What is the all time high quarterly CFO for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly cash flow from operations is -$10.56 M
What is Apogee Therapeutics quarterly CFO year-on-year change?
Over the past year, APGE quarterly cash flow from operations has changed by -$22.64 M (-113.90%)
What is Apogee Therapeutics TTM cash flow from operations?
The current TTM CFO of APGE is -$133.21 M
What is the all time high TTM CFO for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM cash flow from operations is -$10.56 M
What is Apogee Therapeutics TTM CFO year-on-year change?
Over the past year, APGE TTM cash flow from operations has changed by -$88.21 M (-195.99%)